| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 8,722,400 | 8,670,800 | 8,614,700 | 7,759,300 | | Cost of Revenue | 19,497,800 |
-
|
-
| 5,793,700 | | | Gross Profit | (10,775,400) | 8,670,800 | 8,614,700 | 1,965,600 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (11,338,200) | 8,070,200 | 7,859,800 | 1,517,900 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 562,800 | 600,600 | 754,900 | 447,700 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 49,000 | (24,500) | (24,500) | (108,200) | | Earnings Before Interest And Taxes | 611,800 | 576,100 | 730,400 | 339,500 | | Interest Expense | 133,500 | 60,700 | 61,500 | (15,600) | | Income Before Tax | 478,300 | 515,400 | 668,900 | 355,100 | | Income Tax Expense | 152,100 | 168,800 | 231,100 | 160,400 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 326,200 | 346,600 | 437,800 | 194,700 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 326,200 | 346,600 | 437,800 | 194,700 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $326,200 | $346,600 | $437,800 | $194,700 |
|
2.03% Nasdaq 
Income Statement
